Impact on Prognosis of the Surgical Route, Laparoscopy or Laparotomy, for the Surgical Staging of Early Stage Ovarian Cancer-A Study from the FRANCOGYN Group.

Fiche publication

Date publication

octobre 2020

Journal

Journal of clinical medicine

Auteurs

Membres identifiés du Cancéropôle Est :
Pr COUTANT Charles , Pr AKLADIOS Chérif

Tous les auteurs :
Merlier M, Kerbage Y, Pierache A, Ramdane N, Canlorbe G, Bolze PA, Ballester M, Bendifallah S, Ouldamer L, Touboul C, Huchon C, Lavoue V, Dabi Y, Akladios C, Coutant C, Raimond E, Bricou A, Phalippou J, Collinet P, Azaïs H

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/33142772

Résumé

according to the latest ESMO-ESGO recommendations, laparotomy is the standard surgical approach to treat and stage patients with presumed early stage epithelial ovarian cancer (EOC). A few studies have investigated the efficacy and the safety of laparoscopy for the staging of early stage EOC, and this question is still in the center of debates. Recurrence-free survival (RFS) and overall survival (OS) benefits of the minimally invasive surgery (MIS) have still to be specified. The aim of this multicenter and retrospective study is to assess the survival outcomes of laparoscopic staging in comparison with laparotomic staging for patients presenting with an early stage EOC.